Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the partin tables

European Urology

Volumn 43, Issue 1, 2003, Pages 6-11

  Graefen, Markus ^a   Augustin, Herbert ^a   Karakiewicz, Pierre I ^b   Hammerer, Peter G ^a   Haese, Alexander ^a   Palisaar, Juri ^a   Blonski, Jakob ^a   Fernandez, Salvator ^a   Erbersdobler, Andreas ^a   Huland, Hartwig ^a   Djavan, Bob ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c University of Hamburg ^*

Author keywords

Organ confined disease; Partin tables; Prostate cancer; Radical prostatectomy

Indexed keywords

ACCURACY; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; EUROPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; UNITED STATES; VALIDATION PROCESS;

EID: 12244278269     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(02)00497-9     Document Type: Article

References (23)

1. A.W. Partin M.W. Kattan E.N. Subong P.C. Walsh K.J. Wojno J.E. Oesterling Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
2. M. Graefen J. Noldus U. Pichlmeier A. Haese P. Hammerer S. Fernandez Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics Eur. Urol. 36 1999 21 30
3. M.T. Gettman E.J. Bergstralh M. Blute H. Zincke D.G. Bostwick Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis Urology 51 1998 79 85
4. M.W. Kattan J.A. Eastham A.M. Stapleton T.M. Wheeler P.T. Scardino A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J. Natl. Cancer Inst. 90 1998 766 771
5. J.J. Bauer R.R. Connelly I.A. Seterhenn J. Deausen S. Srivastava D.G. McLeod Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer J. Urol. 159 1998 929 933
6. A.V. D’Amico R. Whittington S.B. Malkowicz J. Fondurulia M.H. Chen I. Kaplan Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer J. Clin. Oncol. 17 1999 168 172
7. T.A. Stamey J.E. McNeal C.M. Yemoto B.M. Sigal I.M. Johnstone Biological determinants of cancer progression in men with prostate cancer JAMA 281 1999 1395 1400
8. J. Noldus M. Graefen A. Haese R.P. Henke P. Hammerer H. Huland Stage migration in clinically localized prostate cancer Eur. Urol. 38 2000 74 78
9. A.W. Partin J. Yoo H.B. Carter J.D. Pearson D.W. Chan J.I. Epstein The use of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J. Urol. 150 1993 110 114
10. M.W. Kattan A.M. Stapleton T.M. Wheeler P.T. Scardino Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma Cancer 79 1997 528 537
11. M.L. Blute E.J. Bergstralh A.W. Partin P.C. Walsh M.W. Kattan P.T. Scardino Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer J. Urol. 164 2000 1591 1595
12. J.E. McNeal E.A. Redwine F.S. Freiha T.A. Stamey Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread Am. J. Surg. Pathol. 12 1988 897 906
13. F.H. Schroeder P. Hermanek L. Denis W.R. Fair M.K. Gospodarowicz M. Pavone-Macaluso The TNM classification of prostate cancer Prostate 4 Suppl 1992 129 138
14. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology: The prostate. Philadelphia: Lea & Ferbiger; 1977, p. 171–97.
15. H. Huland D. Hubner R.P. Henke Systematic biopsies and digital rectal examination to identify the nerve-sparing side for radical prostatectomy without risk of positive margin in patients with clinical stage T2, N0 prostatic carcinoma Urology 44 1994 211 214
16. M. Graefen A. Haese U. Pichlmeier P.G. Hammerer J. Noldus K. Butz A validated strategy for side-specific prediction of organ confined prostate cancer: a tool to select for nerve-sparing radical prostatectomy J. Urol. 165 2001 857 863
17. M. Ohori M. Graefen P.T. Scardino Y.M. Hwang S. Kher M.W. Kattan Development of an improved nomogram including features of systematic biopsies to predict organ confined (OC) prostate cancer in patients undergoing radical prostatectomy (RP) J. Urol. 165 Suppl 2001 240 241 [abstract 991]
18. S. Soh M.W. Kattan S. Berkman T.M. Wheeler P.T. Scardino Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J. Urol. 157 1997 2212 2218
19. S. Conrad M. Graefen U. Pichlmeier R.P. Henke P.G. Hammerer H. Huland Systematic sextant biopsies improve preoperative prediction of pelvic lymph nodemetastases in patients with clinically localized prostatic carcinoma J. Urol. 159 1998 2023 2029
20. M. Han P.B. Snow J.M. Brandt A.W. Partin Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma Cancer 91 Suppl 2001 1661 1666
21. B. Djavan M. Remzi C. Seitz P. Snow M. Marberger Novel Artificial Neural Network for Early Detection of Prostate Cancer J. Clin. Oncol. 201 4 2002 921 929
22. Han M, Snow PB, Brandt JM, Partin AW. Artificial Neural Networks for the Prediction of Pathologic Stage in Prostate Carcinoma. Cancer 2001;91(Suppl 8).
23. S.R. Potter M.G. Miller L.A. Mangold K.A. Jones J.I. Epstein R.W. Veltri Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomy Urology 54 5 1999 791 795